- Issuer ticker
-
GLSI
- Reported as of
-
28 Jul 2026
- Net transaction value
-
+$29,555
- SEC form
-
4
- Accepted by SEC
-
30 Jul 2026, 06:05:16 UTC
Filing notes and source
Key filing fact
Snehal Patel filed Form 4 for Greenwich LifeSciences, Inc. (GLSI) on 30 Jul 2026.
Key facts
- This page summarizes Snehal Patel's Form 4 filing for Greenwich LifeSciences, Inc. (GLSI).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 30 Jul 2026, 06:05.
Change
- Previous filing in this sequence was filed on 29 Jul 2026.
- Current net transaction value: +$29,555.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001806920
Primary reporting owner
Patel Snehal
- Relationship
-
CEO and CFO, Director, 10%+ Owner
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GLSI
transaction
Common Stock
Purchase
- Transaction value
- $20,385
- Shares
- +1,500
- Change %
- +0.03%
- Price
-
$13.59
- Shares after
- 5,610,702
- Date
- 28 Jul 2026
- Ownership
- Direct
GLSI
transaction
Common Stock
Purchase
- Transaction value
- $9,170
- Shares
- +700
- Change %
- +0.01%
- Price
-
$13.10
- Shares after
- 5,611,402
- Date
- 29 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.